HGF and lung cancer: Importantly, anti-HGF neutralizing antibody and the natural HGF inhibitor NK4 significantly overcome the gefitinib resistance in culture and in tumor xenografts raised by lung cancer cells admixed with HGF-producing human fibroblasts in mice treated with gefitinib.